Filter by: patients
Home > Community Treatment Reports and Side Effects > Sumatriptan subcutaneous Treatment Report
What is Sumatriptan subcutaneous?

Sumatriptan is a selective serotonin receptor agonist used to relieve the symptoms of migraine headaches. It works by narrowing blood vessels and stopping pain signals in the brain. Sumatriptan does not prevent migraine attacks. The injectable form is used because it acts faster than oral tablets.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Migraine headaches 17 3 Efficacy_major Efficacy_moderate
Migraine 5 2 Efficacy_major Efficacy_slight
Ocular migraine aura 1 0
Complex Confusional Migraine 1 0
Atypical Migraine 1 1 Efficacy_slight
Headaches 1 0

See all 20 patients currently taking Sumatriptan subcutaneous

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 3
Mild
 0
None
 3

Commonly reported side effects, conditions, and hospitalizations associated with Sumatriptan subcutaneous

Muscle fatigue 1
Sleepiness 1
Stomach upset 1
Muscle tightness 1

Reported Dosages

  6mg/0.5mL as needed 6mg as needed 4mg/0.5mL as needed 4 mg/0.5 mL daily
  15 Number of Patients: 15 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Sumatriptan subcutaneous (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3   Did not seem to work: 75%
Doctor's advice 2   Doctor's advice: 50%
Course of treatment ended 1   Course of treatment ended: 25%

See all 4 patients who’ve stopped taking Sumatriptan subcutaneous

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Sumatriptan subcutaneous

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Sumatriptan subcutaneous

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Sumatriptan subcutaneous

Always
 5 83%
Usually
 0 0%
Sometimes
 1 17%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Sumatriptan subcutaneous

Very
 0 0%
Somewhat
 1 17%
A little
 3 50%
Not at all
 2 33%

Cost

Paid out of pocket

Cost of Sumatriptan subcutaneous

$200+
 1 25%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 1 25%
< $25
 2 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.